Member Posts > Cardiol Therapeutics to Highlight Cardiovascular Innovation at TD Cowen Health Care Conference
Cardiol Therapeutics Inc., a clinical-stage life sciences company committed to developing novel anti-inflammatory and anti-fibrotic therapies for cardiovascular diseases, will participate in the TD Cowen 45th Annual Health Care Conference. The company's presentation, scheduled for March 5, 2025, at 11:10 AM EST in Boston, will provide an opportunity to showcase its latest scientific and clinical progress to investors, researchers, and industry professionals.
The company has a strong track record of participating in major healthcare conferences. Earlier in 2025, Cardiol Therapeutics was featured at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, where it highlighted advancements in its pipeline. Additionally, in September 2023, CEO David Elsley spoke at the Cantor Fitzgerald 2023 Global Healthcare Conference, emphasizing the company's strategy for developing next-generation therapies for heart disease.
With each presentation, Cardiol Therapeutics continues to demonstrate its leadership in cardiovascular research, reinforcing its commitment to improving patient outcomes and advancing medical innovation.

#CardiolTherapeutics #CardiovascularResearch #HeartHealth #BiotechInvestments #PharmaceuticalInnovation #MedicalTechnology